Tuesday - April 22, 2025
TORONTO, April 27, 2023 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities" or "MFC") will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023. MFC's financial statements and management's discussion and analysis for the three-month period ended March 31, 2023 will be filed on SEDAR at www.sedar.com following the release, and will also be available on the same day on MFC's website at www.medicalfacilitiescorp.ca. Management will host an earnings conference call to review the financial results at 8:30 a.m. ET the same morning.
All interested parties may join the conference call by dialing 416-764-8650 or 1-888-664-6383 approximately 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins. A question-and-answer session will follow management's prepared remarks, at which time the operator will provide instructions to qualified equity analysts for submitting questions.
To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/3o9IPRy https://emportal.ink/40SO72D to receive an instant automated call back.
A live audio webcast of the call will be available at https://bit.ly/MFC2023Q1. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on MFC's website following the call date.
Medical Facilities, in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns a controlling interest in five ambulatory surgery centers located in Michigan, Missouri, Nebraska, Ohio, and Pennsylvania. MFC also owns a non-controlling interest in an ASC in Missouri. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASCs specialize in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.
Last Trade: | C$14.93 |
Daily Change: | -0.11 -0.73 |
Daily Volume: | 27,091 |
Market Cap: | C$349.360M |
March 03, 2025 November 07, 2024 August 06, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load